Biomedcode’ s R&D team participated in the activities of the 1st BSRC Al. Fleming Retreat. R&D projects were presented in three posters and scientific results were discussed with BSRC Al. Fleming scientists. Biomedcode’s overall activities were presented in a regular talk.
Biomedcode presents an abstract entitled “Characterization Of Novel Humanized Il-17 Preclinical Platforms For The Efficacy Evaluation Of Anti-Human Il17 Therapeutics” in the 39thEuropean Workshop for Rheumatology Research that takes place February 28-March 2 in Lyon France.